Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases
详细信息 查看全文
- 作者：Lei Zhang ; Yan-Jun Su ; Jia-Yue Chen ; Zhi-Chao Liao…
- 关键词：Bone metastases ; Health ; related quality of life ; EORTC QLQ ; BM22 ; Validation
- 刊名：Supportive Care in Cancer
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：24
- 期：3
- 页码：1019-1024
- 全文大小：273 KB
- 参考文献：1.Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A et al (2012) International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5):1457–1465. doi:10.1002/cncr.26410 CrossRef PubMed
2.Wan C, Meng Q, Yang Z, Tu X, Feng C, Tang X, Zhang C (2008) Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Ann Oncol 19:2053–2060. doi:10.1093/annonc/mdn417 PubMedCentral CrossRef PubMed
3.Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A et al (2009) The European Organization for research and treatment of cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 45(7):1146–1152. doi:10.1016/j.ejca.2008.11.013 CrossRef PubMed
4.Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V et al (2012) Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys 84(3):e337–e342. doi:10.1016/j.ijrobp.2012.05.028 CrossRef PubMed
5.Chow E, Bottomley A (2009) Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res 9(5):461–465. doi:10.1586/erp.09.50 CrossRef PubMed
6.Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A et al (2011) The EORTC QLQC30 Scoring Manual. 3rd ed. Brussels, Belgium. European Organization for research and treatment of cancer. Support Care Cancer 19(11):1753–1760CrossRef
7.Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska TM, Głowacki R et al (2014) Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases. Qual Life Res 23(2):527–532. doi:10.1007/s11136-013-0486-6 CrossRef PubMed
8.Broom R, Du H, Clemons M, Eton D, Dranitsaris G, Simmons C, Ooi W, Cella D (2008) Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the functional assessment of cancer therapy-bone pain. J Pain Symptom Manage 38(2):244–257. doi:10.1016/j.jpainsymman.2008.08.005 CrossRef
9.Popovic M, Nguyen J, Chen E, Di Giovanni J, Liang Z, Chow E (2012) Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res 12(2):213–219. doi:10.1586/erp.11.99 CrossRef PubMed
10.Yekaninejad MS, Ahmadzadeh A, Mosavi SH, Saffari M, Pakpour AH, Tolooei F, Chow E, Bottomley A (2014) The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.Expert. Rev Pharmacoecon Outcomes Res 14(1):147–156. doi:10.1586/14737167.2014.864559 CrossRef - 作者单位：Lei Zhang (1)
Yan-Jun Su (1)
Jia-Yue Chen (3)
Zhi-Chao Liao (2)
Zhi-Qin Luo (4)
Shu-Min Xie (5)
Jing Zhang (3)
Yun-Shou Lin (3)
Hui Guo (3)
Wei-Lin Sun (3)
Begüm Pekbay (6)
Adam R Miller (7)
Le Luo (8)
Yu-Hua Rui (5)
Mo-Han Li (5)
Chang-Li Wang (1)
1. Department of Thoracic Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center, Tianjin, 300060, People’s Republic of China
3. Tianjin Medical University, Tianjin, People’s Republic of China
2. Department of Bone and Softissue Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China
4. Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, People’s Republic of China
5. Xiangya School of Medicine, Central South University, Changsha, People’s Republic of China
6. Erasmus University Rotterdam, Rotterdam, Netherlands
7. Indiana University School of Medicine, Indianapolis, IN, USA
8. Department of Radiation Oncology, Tumor Hospital Xiangya School of Medicine of Central South University, Changsha, People’s Republic of China - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Oncology
Nursing
Nursing Management and Research
Pain Medicine
Rehabilitation Medicine - 出版者：Springer Berlin / Heidelberg
- ISSN：1433-7339
文摘
Purpose Our aim is to test the validity, reliability, and acceptability of the Chinese version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Bone Metastases 22 (EORTC QLQ-BM22) module to assess health-related quality of life (HRQOL) in patients with bone metastases in China.